BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
ORGANIZER;CN=Tyra Biosciences, Inc.:MAILTO:no-reply@gcs-web.com
DTEND:
UID:c21d222a-394c-48b6-8cf1-d3bcac1ddc8b
DTSTAMP:1788588450
LOCATION:https://edge.media-server.com/mmc/p/3uv26c2o
DESCRIPTION:Event Details https://ir.tyra.bio/events/event-details/tyra-biosciences-host-conference-call-initial-results-oral-dabogratinib\n\nWebcast: https://edge.media-server.com/mmc/p/3uv26c2o
URL;VALUE=URI:https://edge.media-server.com/mmc/p/3uv26c2o
SUMMARY:Tyra Biosciences, Inc. - Conference call and Webcast - Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study 
DTSTART:20260909T120000Z
END:VEVENT
END:VCALENDAR